India to expand access to J&J's TB drug this year

MUMBAI (Reuters) - India's top tuberculosis fighter said the government will expand access to Johnson & Johnson's breakthrough TB drug this year, but health experts warn much more needs to be done to eliminate the superbug by 2025.